Literature DB >> 33165753

Trends in Utilization and Perioperative Outcomes in Robotic-assisted Bariatric surgery using the MBSAQIP database: A 4-Year Analysis.

Thomas Scarritt1, Chiu-Hsieh Hsu2, Felipe B Maegawa1, Alfonso E Ayala1, Matthew Mobily1, Iman Ghaderi3.   

Abstract

PURPOSE: Robotic-assisted surgery has become increasingly popular across surgical subspecialties. We aimed to analyze trends in the national utilization and outcomes in bariatric surgery.
MATERIALS AND METHODS: The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP®) data for 2015-2018 was queried. We included robotic-assisted sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), adjustable gastric band (AGB), biliopancreatic diversion with duodenal switch (BPD-DS), and revisional cases. The Kruskal-Wallis test or Wilcoxon rank-sum were used for comparing continuous variables and Cochran-Armitage trend analysis for categorical variables when comparing years, or with Fisher's Exact Test when directly comparing categories.
RESULTS: Of 760,076 bariatric cases performed between 2015 and 2018, 7.4% with robotic and 90.4% with laparoscopic approach. SG constituted 61.3% of robotic volume. Utilization of robotic surgery increased 1.96-fold; SG represented the most substantial increase of 2.16-fold, followed by a 1.53-fold in RYGB. The 30-day readmission and re-intervention rates decreased from 5.63% to 4.78% (p<0.01), and 2.31% to 1.46% (p<0.01), respectively. The overall leak rate improved from 0.64% to 0.39% (p=0.01). Mortality and re-operations remained statistically unchanged. When compared to laparoscopic approach, the operative time were significantly longer in the robotic group. Regarding postoperative outcomes, when adjusted for patient characteristics, there were no differences between two approaches except a higher leak rate in robotic group in 2015.
CONCLUSION: A steady increase in robotic bariatric surgery is apparent. While the operative time remains significantly longer in the robotic group, trends indicate improvement in key quality metrics and patient outcomes as utilization increases.

Entities:  

Keywords:  Bariatric surgery; Robotic surgery; laparoscopic; outcomes; short-term complications

Mesh:

Year:  2020        PMID: 33165753     DOI: 10.1007/s11695-020-05055-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  1 in total

Review 1.  Urologic Robotic Surgery.

Authors:  David Mikhail; Joseph Sarcona; Mina Mekhail; Lee Richstone
Journal:  Surg Clin North Am       Date:  2020-04       Impact factor: 2.741

  1 in total
  5 in total

1.  A fully stapled technique for gastrojejunal anastomosis creation in robotic Roux-en-Y gastric bypass.

Authors:  Logan P Prager; Mallorie L Huff; Sarah E Alfieri; Joseph A Sujka
Journal:  Langenbecks Arch Surg       Date:  2022-08-05       Impact factor: 2.895

2.  Robot-assisted versus laparoscopic approach to concurrent bariatric surgery and hiatal hernia repair: propensity score matching analysis using the 2015-2018 MBSAQIP.

Authors:  Raul Sebastian; Omar M Ghanem; Jorge Cornejo; Thomas Ruttger; Matthew Mayuiers; Gina Adrales; Christina Li
Journal:  Surg Endosc       Date:  2022-01-12       Impact factor: 3.453

Review 3.  Current Status of Robot-Assisted Revisional Bariatric Surgery.

Authors:  Carolina Vanetta; Nicolás H Dreifuss; Francisco Schlottmann; Alberto Mangano; Antonio Cubisino; Valentina Valle; Carolina Baz; Francesco M Bianco; Chandra Hassan; Antonio Gangemi; Mario A Masrur
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

4.  Factors Related to Weight Gain in Subjects with Sleeve Gastrectomy During Lockdown by the COVID-19 Pandemic.

Authors:  Daniel de Luis; Olatz Izaola; David Primo; Emilia Gómez; Beatriz Torres; Juan José López Gómez; David Pacheco
Journal:  Obes Surg       Date:  2021-02-01       Impact factor: 4.129

5.  Robotic Roux-en-Y Gastric Bypass: A Single Surgeon's Experience with 527 Consecutive Patients.

Authors:  Abdulkadir Bedirli; Aydin Yavuz; Kursat Dikmen; Cagri Buyukkasap; Safa Ozaydin
Journal:  JSLS       Date:  2022 Jan-Mar       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.